Drug · DIN 02554550
SOLUFY
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 15, 2025; first marketed August 15, 2025.
- Drug Identification Number (DIN)
- 02554550
- Company (DIN owner)
- Orimed Pharma Inc.Boucherville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Oral
- Therapeutic class (ATC)
- Aripiprazole N05AX12
- Class
- Human
- Record last updated
- July 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ARIPIPRAZOLE | 1 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 28, 2025: NOC 35432Supplement to a New Drug Submission (SNDS) · Administrative: Change in product name
- January 15, 2025: NOC 34691New Drug Submission (NDS)